Blue Note logo


Blue Note Explores the Impact of Technology on Cancer Care at the NCCN Virtual Policy Summit

November 2021

On September 9, 2021, Laura Chavaree, head of patient engagement at Blue Note Therapeutics, joined other leading experts during the National Comprehensive Cancer Network (NCCN) Virtual Policy Summit: The Impact of Technology on Cancer Care in 2021.

The program brought together speakers and panelists to discuss how innovation impacts patient outcomes, best practices for the use of technology within care delivery, and policies that influence and support technological advancements and access to high-quality care. You can learn more about digital tools to support cancer patients, including Blue Note’s COVID Cancer Care program, through NCCN’s Toolkit of Digital Resources.

View Laura’s presentation here, the full Summit recording here and the NCCN press release here.